MEG3 modulates TIGIT expression and CD4 + T cell activation through absorbing miR-23a

Area of Science:

• Immunology
• Molecular Biology
• Hematology

Background:

• T cells contribute to bone marrow failure in aplastic anemia (AA).
• Long non-coding RNA MEG3 regulates gene expression and T cell differentiation.
• T cell immunoglobulin and immunoreceptor tyrosine-based inhibition motif (TIGIT) is crucial for CD4+ T cell function.

Purpose of the Study:

• Investigate the role of MEG3 in CD4+ T cells from AA patients.
• Determine the mechanism by which MEG3 affects T cell function and AA pathogenesis.
• Evaluate the therapeutic potential of MEG3 in an AA mouse model.

Main Methods:

• Quantified MEG3 expression in CD4+ T cells from AA patients.
• Assessed the impact of MEG3 on CD4+ T cell proliferation, cytokine production (IFN-γ, TNF-α), and key transcription factors (TIGIT, T-bet, RORγt).
• Utilized a mouse model of AA to test the therapeutic effects of MEG3 overexpression in CD4+ T cells.

Main Results:

• MEG3 expression was significantly reduced in CD4+ T cells of AA patients.
• MEG3 modulated CD4+ T cell proliferation and cytokine profiles, influencing TIGIT, T-bet, and RORγt expression.
• MEG3 overexpression in CD4+ T cells reduced Th1/Th17 expansion, improved red blood cell counts, decreased serum inflammatory cytokines, and enhanced survival in the AA mouse model.

Conclusions:

• MEG3 regulates TIGIT expression and CD4+ T cell activation by sequestering miR-23a.
• MEG3 shows therapeutic potential for autoimmune-mediated aplastic anemia.